Survey of perinatal hepatitis B virus transmission after Korean National Prevention Program in a tertiary hospital |
Kim, Jae Hoon
(Gachon University School of Medicine, Gachon University Gil Medical Center)
Kim, Ju Seung (Department of Internal Medicine, Gachon University Gil Medical Center) Lee, Jong Joon (Department of Internal Medicine, Gachon University Gil Medical Center) Kim, Jung Ho (Department of Internal Medicine, Gachon University Gil Medical Center) Kim, Suk Young (Department of Obstetrics and Gynecology, Gachon University Gil Medical Center) Jung, Young Kul (Department of Internal Medicine, Gachon University Gil Medical Center) Kwon, Oh Sang (Department of Internal Medicine, Gachon University Gil Medical Center) Kim, Yun Soo (Department of Internal Medicine, Gachon University Gil Medical Center) Choi, Duck Joo (Department of Internal Medicine, Gachon University Gil Medical Center) Kim, Ju Hyun (Department of Internal Medicine, Gachon University Gil Medical Center) |
1 | Korean Association for the Study of the Liver. KASL clinical practice guidelines: management of chronic hepatitis B. Clin Mol Hepatol 2012;18:109-162. DOI |
2 | Ding Y, Sheng Q, Ma L, Dou X. Chronic HBV infection among pregnant women and their infants in Shenyang, China. Virol J 2013;10:17. DOI |
3 | Yin Y, Wu L, Zhang J, Zhou J, Zhang P, Hou H. Identification of risk factors associated with immunoprophylaxis failure to prevent the vertical transmission of hepatitis B virus. J Infect 2013;66:447-452. DOI ScienceOn |
4 | Korea Centers for Disease Control and Prevention. 2006 Report of the Korea Centers for Disease Control and Prevention. Seoul: Korea Centers for Disease Control and Prevention, 2004:365-367. |
5 | Choe BH. The epidemiology and present status of chronic hepatitis B in Korean children. Korean J Pediatr 2008;51:696-703. DOI ScienceOn |
6 | Kim BW, Seo K, Park SK, et al. Evaluation of prevention program for neonatal vertical transmission from HBsAg positive mother in Korea. Korean J Obstet Gynecol 2005;48:2067-2072. |
7 | Korea Centers for Disease Control and Prevention. The Fifth Korea National Health and Nutrition Examination Survey (KNHANES V-2): Korea Health Statistics 2011. Cheongwon: Korea Centers for Disease Control and Prevention, 2012:464-466. |
8 | Kang JH, Moon JW, Kong SH, Hwang KS, Mok JS, Lee HJ. Comparison of the seroconversion rate after primary hepatitis B vaccination and after revaccination of non-responders in full-term infants according to mother's HBsAg seropositivity. Korean J Pediatr 2008;51:1165-1171. DOI |
9 | Plitt SS, Somily AM, Singh AE. Outcomes from a Canadian public health prenatal screening program for hepatitis B: 1997-2004. Can J Public Health 2007;98:194-197. |
10 | Han L, Zhang HW, Xie JX, Zhang Q, Wang HY, Cao GW. A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus. World J Gastroenterol 2011;17:4321-4333. DOI |
11 | Deng M, Zhou X, Gao S, et al. The effects of telbivudine in late pregnancy to prevent intrauterine transmission of the hepatitis B virus: a systematic review and meta- analysis. Virol J 2012;9:185. DOI |
12 | Yogeswaran K, Fung SK. Chronic hepatitis B in pregnancy: unique challenges and opportunities. Korean J Hepatol 2011;17:1-8. DOI ScienceOn |
13 | Korea Centers for Disease Control and Prevention. Communicable Diseases Monthly Report: Hepatitis B Vertical Transmission Prevention Program. Seoul: Korea Centers for Disease Control and Prevention, 2008:14. |
14 | Hyams KC. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 1995;20:992-1000. DOI ScienceOn |
15 | Chun BY, Lee MK, Rho YK. The prevalence of hepatitis B surface antigen among Korean by literature review. Korean J Epidemiol 1992;14:70-78. |
16 | Seo K, Park SK, Kim YT, Park O. The prevalence of HBsAg positive parturients in Korea. Korean J Obstet Gynecol 2005;48:2119-2124. |
17 | Okada K, Kamiyama I, Inomata M, Imai M, Miyakawa Y. e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med 1976;294:746-749. DOI ScienceOn |
18 | Beasley RP, Trepo C, Stevens CE, Szmuness W. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol 1977;105:94-98. DOI |
19 | Lin HH, Chang MH, Chen DS, et al. Early predictor of the efficacy of immunoprophylaxis against perinatal hepatitis B transmission: analysis of prophylaxis failure. Vaccine 1991;9:457-460. DOI |
20 | Ngui SL, Andrews NJ, Underhill GS, Heptonstall J, Teo CG. Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors. Clin Infect Dis 1998;27:100-106. DOI ScienceOn |
21 | Ip HM, Lelie PN, Wong VC, Kuhns MC, Reesink HW. Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA. Lancet 1989;1:406-410. |
22 | Lee SD, Lo KJ, Wu JC, et al. Prevention of maternal-infant hepatitis B virus transmission by immunization: the role of serum hepatitis B virus DNA. Hepatology 1986;6:369-373. DOI |
23 | Chen DS. Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B. J Hepatol 2009;50:805-816. DOI |
24 | Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975;292:771-774. DOI ScienceOn |
25 | Korea Centers for Disease Control and Prevention. The Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV). Seoul: Korea Centers for Disease Control and Prevention, 2007:70-71. |
26 | Park NH, Chung YH, Lee HS. Impacts of vaccination on hepatitis B viral infections in Korea over a 25-year period. Intervirology 2010;53:20-28. DOI ScienceOn |
27 | Kim JH. Perinatal hepatitis B virus infection: viral factors in the mechanism of perinatal immunoprophylaxis failure. Korean J Pediatr 2004;47:123-130. |